COMP <GO>
CRON vs JNJ // RSI-14 & 200D SMA MOMENTUM
Cronos Group Inc. Common Share (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: CRON 2
— JNJ 8
▲ RSI-14 & 200D SMA MOMENTUM LEADER: JNJ
LAST: $3.36 (+0.30%) • MKT CAP: $1.24B
rsi-technicals
55.0
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
rsi-technicals
62.1
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRON VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CRON | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 42.80% | 67.90% | -25.10 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -4.50% | 25.50% | -30.00 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.01% | 2.97% | -2.96 | JNJ | /fcf-yield <GO> |
| Operating Margin | -11.90% | 34.70% | -46.60 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -2.00% | 28.50% | -30.50 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 24.60% | 6.00% | +18.60 | CRON | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 15.20 | 5.59 | +9.61 | CRON | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 55.0 | 62.1 | -7.10 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.24B | $662.49B | -$661.25B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CRON REV | JNJ REV | CRON GROSS % | JNJ GROSS % | CRON FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $146.6M | $94.19B | 42.8% | 67.9% | $149.0K | $19.70B |
| FY 2024 | $117.6M | $88.82B | 21.4% | 69.1% | $6.4M | $19.84B |
| FY 2023 | $87.2M | $85.16B | — | — | -$42.8M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRON // BETA —
JNJ // BETA 1.08